智通财经APP讯,再鼎医药(09688)发布公告,公司于授出日期根据2024年股权激励计划授出13.68万份购股权(以美国存托股份计)、7.53万份受限制股份单位(以美国存托股份计)。
所授出购股权涉及的相关股份数目:1,368,190;所授出受限制股份单位涉及的相关股份数目:752,880。
智通财经APP讯,再鼎医药(09688)发布公告,公司于授出日期根据2024年股权激励计划授出13.68万份购股权(以美国存托股份计)、7.53万份受限制股份单位(以美国存托股份计)。
所授出购股权涉及的相关股份数目:1,368,190;所授出受限制股份单位涉及的相关股份数目:752,880。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.